Lydall Inc (LDL) Fundamental Analysis & Valuation

NYSE:LDL

62.09
+0.01 (+0.02%)
At close: Sep 30, 2021
62.09
0 (0%)
After Hours: 9/30/2021, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This LDL fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

Taking everything into account, LDL scores 2 out of 10 in our fundamental rating. LDL was compared to 130 industry peers in the Machinery industry. LDL may be in some trouble as it scores bad on both profitability and health. LDL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. LDL Profitability Analysis

1.1 Basic Checks

  • LDL had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -0.07%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 1.94%
PM (TTM) -0.07%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. LDL Health Analysis

2.1 Basic Checks

  • LDL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

  • An Altman-Z score of 3.11 indicates that LDL is not in any danger for bankruptcy at the moment.
  • LDL has a Debt/Equity ratio of 0.91. This is a neutral value indicating LDL is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 3.11
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • A Current Ratio of 1.95 indicates that LDL should not have too much problems paying its short term obligations.
  • A Quick Ratio of 1.48 indicates that LDL should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.48

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. LDL Growth Analysis

3.1 Past

  • LDL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1900.00%, which is quite impressive.
  • The Revenue has grown by 16.23% in the past year. This is quite good.
  • LDL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.81% yearly.
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%285.19%
Revenue 1Y (TTM)16.23%
Revenue growth 3Y3.04%
Revenue growth 5Y7.81%
Sales Q2Q%51.71%

3.2 Future

  • The Earnings Per Share is expected to grow by 406.52% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 11.38% on average over the next years. This is quite good.
EPS Next Y9392%
EPS Next 2Y939.47%
EPS Next 3Y541.91%
EPS Next 5Y406.52%
Revenue Next Year18.7%
Revenue Next 2Y11.55%
Revenue Next 3Y11.26%
Revenue Next 5Y11.38%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LDL Yearly Revenue VS EstimatesLDL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
LDL Yearly EPS VS EstimatesLDL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

2

4. LDL Valuation Analysis

4.1 Price/Earnings Ratio

  • LDL is valuated quite expensively with a Price/Earnings ratio of 68.99.
  • LDL's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.03.
  • With a Price/Forward Earnings ratio of 29.27, LDL can be considered very expensive at the moment.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.11, LDL is valued at the same level.
Industry RankSector Rank
PE 68.99
Fwd PE 29.27
LDL Price Earnings VS Forward Price EarningsLDL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.25
LDL Per share dataLDL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as LDL's earnings are expected to grow with 541.91% in the coming years.
PEG (NY)0.01
PEG (5Y)N/A
EPS Next 2Y939.47%
EPS Next 3Y541.91%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. LDL Dividend Analysis

5.1 Amount

  • No dividends for LDL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

LDL Fundamentals: All Metrics, Ratios and Statistics

Lydall Inc

NYSE:LDL (9/30/2021, 8:04:00 PM)

After market: 62.09 0 (0%)

62.09

+0.01 (+0.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners4.69%
Ins Owner Change0%
Market Cap1.12B
Revenue(TTM)866.20M
Net Income(TTM)-573.00K
Analysts0
Price Target63.34 (2.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 68.99
Fwd PE 29.27
P/S 1.29
P/FCF N/A
P/OCF N/A
P/B 4.07
P/tB N/A
EV/EBITDA 18.25
EPS(TTM)0.9
EY1.45%
EPS(NY)2.12
Fwd EY3.42%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS48.02
BVpS15.26
TBVpSN/A
PEG (NY)0.01
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.07%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 1.94%
PM (TTM) -0.07%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.95
Quick Ratio 1.48
Altman-Z 3.11
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1900%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%285.19%
EPS Next Y9392%
EPS Next 2Y939.47%
EPS Next 3Y541.91%
EPS Next 5Y406.52%
Revenue 1Y (TTM)16.23%
Revenue growth 3Y3.04%
Revenue growth 5Y7.81%
Sales Q2Q%51.71%
Revenue Next Year18.7%
Revenue Next 2Y11.55%
Revenue Next 3Y11.26%
Revenue Next 5Y11.38%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Lydall Inc / LDL FAQ

What is the ChartMill fundamental rating of Lydall Inc (LDL) stock?

ChartMill assigns a fundamental rating of 4 / 10 to LDL.


What is the valuation status for LDL stock?

ChartMill assigns a valuation rating of 3 / 10 to Lydall Inc (LDL). This can be considered as Overvalued.


Can you provide the profitability details for Lydall Inc?

Lydall Inc (LDL) has a profitability rating of 1 / 10.


What are the PE and PB ratios of Lydall Inc (LDL) stock?

The Price/Earnings (PE) ratio for Lydall Inc (LDL) is 68.99 and the Price/Book (PB) ratio is 4.07.


How sustainable is the dividend of Lydall Inc (LDL) stock?

The dividend rating of Lydall Inc (LDL) is 0 / 10 and the dividend payout ratio is 0%.